Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Liver Cirrhosis

Free Subscription Articles published in Gastroenterology Retrieve available abstracts of 84 articles: HTML format

Single Articles

March 2024
1. GAO F, Seto WK, Zheng MH
   Preventing Overdiagnosis of Nonalcoholic Fatty Liver Disease: Established Cutoff Values for Transient Elastography Are Needed.
   Gastroenterology. 2024;166:541-542.
   PubMed    
   
   
   
2. AN T, Liu L, Li X
   Factors Associated With the Influence of Liver Fibrosis Should Be Fully Considered.
   Gastroenterology. 2024;166:540-541.
   PubMed    
   
   
   February 2024
3. WONG RJ, Yang Z, Cheung R, Singal AK, et al
   Impact of Longitudinal Alcohol Use Patterns on Long-Term Risk of Cirrhosis Among U.S. Veterans with Steatotic Liver Disease.
   Gastroenterology. 2024 Feb 28:S0016-5085(24)00238.
   PubMed     Abstract available
   
   
   January 2024
4. POSE E, Piano S, Juanola A, Gines P, et al
   HEPATORENAL SYNDROME IN CIRRHOSIS.
   Gastroenterology. 2024 Jan 19:S0016-5085(24)00054.
   PubMed     Abstract available
   
   
   
5. LAURIDSEN MM, Gronkjaer LL, Khraibut S, Patel N, et al
   The multi-dimensional challenge of poor oral health in cirrhosis - disparities and solutions.
   Gastroenterology. 2024 Jan 13:S0016-5085(24)00043.
   PubMed    
   
   
   November 2023
6. GARCIA-TSAO G, Abraldes JG, Rich NE, Wong VW, et al
   AGA Clinical Practice Update on the Use of Vasoactive Drugs and Intravenous Albumin in Cirrhosis: Expert Review.
   Gastroenterology. 2023 Nov 17:S0016-5085(23)05143.
   PubMed     Abstract available
   
   
   October 2023
7. AMPUERO J, Berzigotti A
   Prognostication in Advanced Chronic Liver Disease Using Liver Stiffness Measurement: Repetita Iuvant.
   Gastroenterology. 2023;165:829-831.
   PubMed    
   
   
   
8. SEMMLER G, Yang Z, Fritz L, Kock F, et al
   Dynamics in Liver Stiffness Measurements Predict Outcomes in Advanced Chronic Liver Disease.
   Gastroenterology. 2023;165:1041-1052.
   PubMed     Abstract available
   
   
   
9. MAN S, Deng Y, Ma Y, Fu J, et al
   Prevalence of Liver Steatosis and Fibrosis in the General Population and Various High-Risk Populations: A Nationwide Study With 5.7 Million Adults in China.
   Gastroenterology. 2023;165:1025-1040.
   PubMed     Abstract available
   
   
   
10. WATTACHERIL JJ, Abdelmalek MF, Lim JK, Sanyal AJ, et al
    AGA Clinical Practice Update on the Role of Noninvasive Biomarkers in the Evaluation and Management of Nonalcoholic Fatty Liver Disease: Expert Review.
    Gastroenterology. 2023;165:1080-1088.
    PubMed     Abstract available
    
    
    September 2023
11. XIE L, Guo H
    Question on the use of BMI >/= 25 kg/m(2) to define obesity to analyze the incidence and risk factors of hepatic steatosis and hepatic fibrosis in the Chinese population.
    Gastroenterology. 2023 Sep 8:S0016-5085(23)04983.
    PubMed    
    
    
    
12. WANG Y, Huang Y, Chase RC, Li T, et al
    Global Burden of Digestive Diseases: A Systematic Analysis of the Global Burden of Diseases Study, 1990 to 2019.
    Gastroenterology. 2023;165:773-783.
    PubMed     Abstract available
    
    
    
13. INTAGLIATA NM, Rahimi RS, Higuera-de-la-Tijera F, Simonetto DA, et al
    Procedural-Related Bleeding in Hospitalized Patients With Liver Disease (PROC-BLeeD): An International, Prospective, Multicenter Observational Study.
    Gastroenterology. 2023;165:717-732.
    PubMed     Abstract available
    
    
    
14. ZUO T, Xie Q, Liu J, Yang J, et al
    Macrophage-Derived Cathepsin S Remodels the Extracellular Matrix to Promote Liver Fibrogenesis.
    Gastroenterology. 2023;165:746-761.
    PubMed     Abstract available
    
    
    August 2023
15. HUANG DQ, Wilson LA, Behling C, Kleiner DE, et al
    Fibrosis Progression Rate in Biopsy-Proven Nonalcoholic Fatty Liver Disease Among People With Diabetes Versus People Without Diabetes: A Multicenter Study.
    Gastroenterology. 2023;165:463-472.
    PubMed     Abstract available
    
    
    
16. PENG Z, Li S, Pi R
    A Giant Cystic Liver Mass in an Elderly Man.
    Gastroenterology. 2023;165:e5-e7.
    PubMed    
    
    
    July 2023
17. REDDY KR, McLerran D, Marsh T, Parikh N, et al
    Incidence and Risk Factors for Hepatocellular Carcinoma in Cirrhosis: the Multi-center Hepatocellular Carcinoma Early Detection Strategy (HEDS) Study.
    Gastroenterology. 2023 Jul 8:S0016-5085(23)04765.
    PubMed     Abstract available
    
    
    June 2023
18. THIELE M, Suvitaival T, Trost K, Kim M, et al
    Sphingolipids Are Depleted in Alcohol-Related Liver Fibrosis.
    Gastroenterology. 2023;164:1248-1260.
    PubMed     Abstract available
    
    
    May 2023
19. FARIAS AQ, Vilalta AC, Zitelli PM, Pereira G, et al
    Genetic Ancestry, Race, and Severity of Acutely Decompensated Cirrhosis in Latin America.
    Gastroenterology. 2023 May 30:S0016-5085(23)00806.
    PubMed     Abstract available
    
    
    April 2023
20. HAN H, Ge X, Babu Komakula SS, Desert R, et al
    MACROPHAGE-DERIVED OSTEOPONTIN (SPP1) PROTECTS FROM NON-ALCOHOLIC STEATOHEPATITIS.
    Gastroenterology. 2023 Apr 5:S0016-5085(23)00581.
    PubMed     Abstract available
    
    
    March 2023
21. LIU R, Dai Z, Zhu C
    A Rare Cause of Liver Fibrosis in an Adolescent Woman.
    Gastroenterology. 2023;164:340-343.
    PubMed    
    
    
    February 2023
22. CHEN VL, Oliveri A, Miller MJ, Wijarnpreecha K, et al
    PNPLA3 genotype and diabetes identify patients with non-alcoholic fatty liver disease at high risk of incident cirrhosis.
    Gastroenterology. 2023 Feb 7:S0016-5085(23)00113.
    PubMed     Abstract available
    
    
    
23. TOH MR, Wong Yi Ting E, Wong Hei S, Ng Wei Tian A, et al
    Global epidemiology and genetics of hepatocellular carcinoma.
    Gastroenterology. 2023 Feb 2:S0016-5085(23)00105.
    PubMed     Abstract available
    
    
    November 2022
24. WANG Z, Tai Y, Wu H
    A rare cause of abdominal pain after transjugular intrahepatic portosystemic shunt.
    Gastroenterology. 2022 Nov 10. pii: S0016-5085(22)01258.
    PubMed    
    
    
    October 2022
25. AJMERA V, Kim BK, Yang K, Majzoub AM, et al
    Liver Stiffness on Magnetic Resonance Elastography and the MEFIB Index and Liver-Related Outcomes in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Individual Participants.
    Gastroenterology. 2022;163:1079-1089.
    PubMed     Abstract available
    
    
    September 2022
26. MURILLO PEREZ CF, Fisher H, Hiu S, Kareithi D, et al
    Greater Transplant-free Survival in Patients Receiving Obeticholic Acid for Primary Biliary Cholangitis in a Clinical Trial Setting Compared to Real-World External Controls.
    Gastroenterology. 2022 Sep 13. pii: S0016-5085(22)01060.
    PubMed     Abstract available
    
    
    August 2022
27. LO GH
    The beauty and sorrow of using PPI in patients with cirrhosis.
    Gastroenterology. 2022 Aug 3. pii: S0016-5085(22)00892.
    PubMed    
    
    
    June 2022
28. KIM NJ, Vutien P, Berry K, Ioannou GN, et al
    Hepatocellular carcinoma risk declines but remains high enough for screening in the first 7 years after HCV cure with DAAs in patients with cirrhosis or high FIB-4.
    Gastroenterology. 2022 Jun 28. pii: S0016-5085(22)00681.
    PubMed    
    
    
    
29. DUURSMA SS, Verkade HJ, Bodewes FAJA
    Cirrhosis and portal hypertension in compound heterozygous people with CF harboring one F508del CFTR gene mutation.
    Gastroenterology. 2022 Jun 10. pii: S0016-5085(22)00624.
    PubMed    
    
    
    
30. SULLIVAN S, Jirapinyo P, Kumbhari V
    Clinical Care Pathway for the Risk Stratification and Management of Patients With Non-alcoholic Fatty Liver Disease.
    Gastroenterology. 2022;162:2131-2132.
    PubMed    
    
    
    May 2022
31. WANG J, Liu D, Chen S
    Proton Pump Inhibitors for Patients with Cirrhosis: Good Medicine or Poison?
    Gastroenterology. 2022 May 17. pii: S0016-5085(22)00514.
    PubMed    
    
    
    
32. SINGH SP
    Proton pump inhibitor increasing the risk of infection and mortality in cirrhosis- need closer look!
    Gastroenterology. 2022 May 2. pii: S0016-5085(22)00458.
    PubMed    
    
    
    
33. GOUDSMIT BFJ, Putter H, Van Hoek B
    The Model for End-Stage Liver Disease 3.0: An Update Without Proven Accuracy.
    Gastroenterology. 2022;162:1781-1782.
    PubMed    
    
    
    
34. GAN W, Liao B, Li X
    A Rare Cause of Liver Fibrosis in Adulthood.
    Gastroenterology. 2022;162:e1-e3.
    PubMed    
    
    
    April 2022
35. CACCIOLA I
    Effects of PPIs in cirrhotic patients: What do we really know?
    Gastroenterology. 2022 Apr 29. pii: S0016-5085(22)00452.
    PubMed    
    
    
    
36. MAHMUD N, Serper M, Taddei TH, Kaplan DE, et al
    The Association between Proton Pump Inhibitor Exposure and Key Liver-Related Outcomes in Patients with Cirrhosis: A Veterans Affairs Cohort Study.
    Gastroenterology. 2022 Apr 6. pii: S0016-5085(22)00352.
    PubMed     Abstract available
    
    
    
37. QIAN T, Fujiwara N, Koneru B, Ono A, et al
    Molecular Signature Predictive of Long-Term Liver Fibrosis Progression to Inform Antifibrotic Drug Development.
    Gastroenterology. 2022;162:1210-1225.
    PubMed     Abstract available
    
    
    March 2022
38. RUDNICK DA, Huang J, Hidvegi T, Chu AS, et al
    Regulation of PGC1alpha downstream of the insulin signaling pathway plays a role in the hepatic proteotoxicity of mutant alpha1-antitrypsin deficiency variant Z.
    Gastroenterology. 2022 Mar 14. pii: S0016-5085(22)00261.
    PubMed     Abstract available
    
    
    February 2022
39. CARRIQUE L, Lynch J, Selzner N
    We thank Bekki et al and Bhagat et al for their comments on our article "Results of Early Transplantation for Alcohol-Related Cirrhosis: Integrated Addiction Treatment with Low Rate of Relapse". Bekki et al pointed out a trend toward inferior graft su
    Gastroenterology. 2022 Feb 3. pii: S0016-5085(22)00103.
    PubMed    
    
    
    December 2021
40. YANG AH, Gandhi S, Urrunaga NH
    Liver Tumor post Liver Transplantation for Hepatitis C Cirrhosis: An Unusual Cause.
    Gastroenterology. 2021 Dec 26. pii: S0016-5085(21)04161.
    PubMed    
    
    
    
41. KEFALAKES H
    DISPARITIES IN CIRRHOSIS MANAGEMENT OF BLACK PATIENTS: DO WE KNOW WHAT TO ADDRESS?
    Gastroenterology. 2021 Dec 1. pii: S0016-5085(21)03811.
    PubMed    
    
    
    
42. SACK JS, Patel RS, Ahmad J
    Nausea and Vomiting 8 Months After Liver Transplantation.
    Gastroenterology. 2021;161:e12-e14.
    PubMed    
    
    
    November 2021
43. BHAGAT N, Rathi S, Singh V
    Early Transplantation for Alcohol-Related Cirrhosis: Risks, Resources, and Relapse.
    Gastroenterology. 2021 Nov 5. pii: S0016-5085(21)03724.
    PubMed    
    
    
    
44. VARGAS JF, Arab JP
    Pulsatile Epigastric Mass and Liver Masses in a 38-Year-Old Patient With Splenomegaly Since Childhood.
    Gastroenterology. 2021;161:e14-e16.
    PubMed    
    
    
    October 2021
45. LEE TH, Roper J, King L
    MIRROR MIRROR ON THE WALL, WHO IS THE FITTEST OF THEM ALL: A NOVEL PREDICTION MODEL FOR POSTOPERATIVE HEPATIC DECOMPENSATION IN PATIENTS WITH CIRRHOSIS.
    Gastroenterology. 2021 Oct 21. pii: S0016-5085(21)03662.
    PubMed     Abstract available
    
    
    September 2021
46. INTAGLIATA NM, Davitkov P, Allen AM, Falck-Ytter YT, et al
    AGA Technical Review on Coagulation in Cirrhosis.
    Gastroenterology. 2021 Sep 24. pii: S0016-5085(21)03477.
    PubMed    
    
    
    
47. O'SHEA RS, Davitkov P, Ko CW, Rajasekhar A, et al
    AGA Clinical Practice Guideline on the Management of Coagulation Disorders in Patients With Cirrhosis.
    Gastroenterology. 2021 Sep 24. pii: S0016-5085(21)03382.
    PubMed    
    
    
    
48. BEKKI Y, Fenig Y
    Evaluation of Early Liver Transplantation for Alcohol-Related Cirrhosis.
    Gastroenterology. 2021 Sep 13. pii: S0016-5085(21)03491.
    PubMed    
    
    
    August 2021
49. SU F
    COVID-19 and cirrhosis: a combination we must strive to prevent.
    Gastroenterology. 2021 Aug 25. pii: S0016-5085(21)03417.
    PubMed    
    
    
    
50. CARRIQUE L, Quance J, Tan A, Abbey S, et al
    Results of Early Transplantation for Alcohol-Related Cirrhosis: Integrated Addiction Treatment with Low Rate of Relapse.
    Gastroenterology. 2021 Aug 6. pii: S0016-5085(21)03342.
    PubMed     Abstract available
    
    
    July 2021
51. LOOMBA R, Mohseni R, Lucas KJ, Gutierrez JA, et al
    TVB-2640 (FASN inhibitor) for the treatment of nonalcoholic steatohepatitis: FASCINATE-1, a randomized, placebo-controlled Ph2a trial.
    Gastroenterology. 2021 Jul 20. pii: S0016-5085(21)03276.
    PubMed     Abstract available
    
    
    
52. GE J, Pletcher MJ, Lai JC
    Outcomes of SARS-CoV-2 Infection in Patients with Chronic Liver Disease and Cirrhosis: a N3C Study.
    Gastroenterology. 2021 Jul 17. pii: S0016-5085(21)03244.
    PubMed     Abstract available
    
    
    June 2021
53. CHIANG HC, Chien SC, Lin YJ
    Pleural effusion with gastric ulcer.
    Gastroenterology. 2021 Jun 26. pii: S0016-5085(21)03176.
    PubMed    
    
    
    May 2021
54. EDWARDS LA, Goldenberg SD, Shawcross DL
    Meeting the challenge of antimicrobial resistance in cirrhosis: the invisible threat that lies within.
    Gastroenterology. 2021 May 25. pii: S0016-5085(21)03065.
    PubMed    
    
    
    
55. GARCIA-TSAO G, Abraldes JG
    Non-selective beta-blockers in compensated cirrhosis: Preventing variceal hemorrhage or preventing decompensation?
    Gastroenterology. 2021 May 11. pii: S0016-5085(21)02972.
    PubMed    
    
    
    April 2021
56. SHAMSADDINI A, Gillevet PM, Acharya C, Fagan A, et al
    Impact of Antibiotic Resistance Genes in Gut Microbiome of Patients with Cirrhosis.
    Gastroenterology. 2021 Apr 12. pii: S0016-5085(21)00634.
    PubMed     Abstract available
    
    
    March 2021
57. ASSELTA R, Paraboschi EM, Gerussi A, Cordell HJ, et al
    X chromosome contribution to the genetic architecture of primary biliary cholangitis.
    Gastroenterology. 2021 Mar 3. pii: S0016-5085(21)00466.
    PubMed     Abstract available
    
    
    
58. ADENIJI N, Carr RM, Aby ES, Catana AM, et al
    Socioeconomic Factors Contribute to the Higher Risk of COVID-19 in Racial and Ethnic Minorities With Chronic Liver Diseases.
    Gastroenterology. 2021;160:1406-1409.
    PubMed    
    
    
    
59. GOLDBERG D, Ross-Driscoll K, Lynch R
    County Differences in Liver Mortality in the United States: Impact of Sociodemographics, Disease Risk Factors, and Access to Care.
    Gastroenterology. 2021;160:1140-1150.
    PubMed     Abstract available
    
    
    February 2021
60. YOUNOSSI ZM, Corey KE, Lim JK
    AGA Clinical Practice Update on Lifestyle Modification Using Diet and Exercise to Achieve Weight Loss in the Management of Nonalcoholic Fatty Liver Disease: Expert Review.
    Gastroenterology. 2021;160:912-918.
    PubMed     Abstract available
    
    
    January 2021
61. ROCKEY DC, Friedman SL
    Fibrosis regression after eradication of hepatitis C virus - from bench to bedside.
    Gastroenterology. 2021 Jan 30. pii: S0016-5085(21)00330.
    PubMed     Abstract available
    
    
    
62. PAIK JM, Younossi Y, Henry L, Mishra A, et al
    Recent Trends in the Global Burden of Hepatitis B virus (HBV): 2007-2017.
    Gastroenterology. 2021 Jan 6. pii: S0016-5085(21)00029.
    PubMed    
    
    
    December 2020
63. EMDIN CA, Haas M, Ajmera V, Simon TG, et al
    Association of genetic variation with cirrhosis: a multi-trait genome-wide association and gene-environment interaction study.
    Gastroenterology. 2020 Dec 10. pii: S0016-5085(20)35545.
    PubMed     Abstract available
    
    
    
64. YOUNOSSI ZM, Anstee QM, Wai-Sun Wong V, Trauner M, et al
    The Association of Histologic and Non-invasive Tests with Adverse Clinical and Patient-Reported Outcomes in Patients with Advanced Fibrosis Due to Nonalcoholic Steatohepatitis (NASH).
    Gastroenterology. 2020 Dec 8. pii: S0016-5085(20)35529.
    PubMed     Abstract available
    
    
    
65. ARVIND A, Osganian SA, Sjoquist JA, Corey KE, et al
    Epoxygenase-Derived Epoxyeicosatrienoic Acid Mediators Are Associated With Nonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis, and Fibrosis.
    Gastroenterology. 2020;159:2232-2234.
    PubMed    
    
    
    November 2020
66. HSU SJ, Zhang C, Jeong J, Lee SI, et al
    Enhanced meningeal lymphatic drainage ameliorates neuroinflammation and hepatic encephalopathy in cirrhotic rats.
    Gastroenterology. 2020 Nov 20. pii: S0016-5085(20)35439.
    PubMed     Abstract available
    
    
    
67. NOUREDDIN M, Jones C, Alkhouri N, Gomez EV, et al
    Screening for Nonalcoholic Fatty Liver Disease in Persons with Type 2 Diabetes in the United States Is Cost-effective: A Comprehensive Cost-Utility Analysis.
    Gastroenterology. 2020;159:1985-1987.
    PubMed    
    
    
    
68. LANG S, Demir M, Martin A, Jiang L, et al
    Intestinal Virome Signature Associated With Severity of Nonalcoholic Fatty Liver Disease.
    Gastroenterology. 2020;159:1839-1852.
    PubMed     Abstract available
    
    
    October 2020
69. ASEEM SO, Jalan-Sakrikar N, Chi C, Navarro-Corcuera A, et al
    Epigenomic Evaluation of Cholangiocyte TGFbeta Signaling Identifies a Selective Role for Histone 3 Lysine 9 Acetylation in Biliary Fibrosis.
    Gastroenterology. 2020 Oct 12. pii: S0016-5085(20)35245.
    PubMed     Abstract available
    
    
    
70. DE VRIES E, Bolier R, Goet J, Pares A, et al
    Fibrates for itch (FITCH) in fibrosing cholangiopathies: a double blind, randomized, placebo-controlled trial.
    Gastroenterology. 2020 Oct 5. pii: S0016-5085(20)35226.
    PubMed     Abstract available
    
    
    
71. ROMEO S
    MARC1 and HNRNPUL1: Two Novel Players in Alcohol-related Liver Disease.
    Gastroenterology. 2020;159:1231-1232.
    PubMed    
    
    
    August 2020
72. HARRISON SA, Neff G, Guy CD, Bashir MR, et al
    Efficacy and Safety of Aldafermin, an Engineered FGF19 Analog, in a Randomized, Double-Blind, Placebo-Controlled Trial of Patients With Nonalcoholic Steatohepatitis.
    Gastroenterology. 2020 Aug 8. pii: S0016-5085(20)35018.
    PubMed     Abstract available
    
    
    
73. NABI O, Lacombe K, Boursier J, Mathurin P, et al
    Prevalence and Risk Factors of Nonalcoholic Fatty Liver Disease and Advanced Fibrosis in General Population: the French Nationwide NASH-CO Study.
    Gastroenterology. 2020;159:791-793.
    PubMed    
    
    
    
74. SCHNEIDER CV, Hamesch K, Gross A, Mandorfer M, et al
    Liver Phenotypes of European Adults Heterozygous or Homozygous for Pi *Z Variant of AAT (Pi *MZ vs Pi *ZZ genotype) and Noncarriers.
    Gastroenterology. 2020;159:534-548.
    PubMed     Abstract available
    
    
    
75. GUPTA V, Gupta I, Park J, Bram Y, et al
    Hedgehog Signaling Demarcates a Niche of Fibrogenic Peribiliary Mesenchymal Cells.
    Gastroenterology. 2020;159:624-638.
    PubMed     Abstract available
    
    
    June 2020
76. LASSAILLY G, Caiazzo R, Ntandja-Wandji LC, Gnemmi V, et al
    Bariatric Surgery Provides Long-term Resolution of Nonalcoholic Steatohepatitis and Regression of Fibrosis.
    Gastroenterology. 2020 Jun 15. pii: S0016-5085(20)34758.
    PubMed     Abstract available
    
    
    May 2020
77. TAYLOR RS, Taylor RJ, Bayliss S, Hagstrom H, et al
    Association Between Fibrosis Stage and Outcomes of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
    Gastroenterology. 2020;158:1611-1625.
    PubMed     Abstract available
    
    
    
78. SCORLETTI E, Afolabi PR, Miles EA, Smith DE, et al
    Synbiotics Alter Fecal Microbiomes, But Not Liver Fat or Fibrosis, in a Randomized Trial of Patients With Nonalcoholic Fatty Liver Disease.
    Gastroenterology. 2020;158:1597-1610.
    PubMed     Abstract available
    
    
    
79. GOLDNER D, Lavine JE
    Nonalcoholic Fatty Liver Disease in Children: Unique Considerations and Challenges.
    Gastroenterology. 2020;158:1967-1983.
    PubMed     Abstract available
    
    
    
80. SCHWABE RF, Tabas I, Pajvani UB
    Mechanisms of Fibrosis Development in Nonalcoholic Steatohepatitis.
    Gastroenterology. 2020;158:1913-1928.
    PubMed     Abstract available
    
    
    March 2020
81. SAHIN-TOTH M
    Channelopathy of the pancreas causes chronic pancreatitis.
    Gastroenterology. 2020 Mar 20. pii: S0016-5085(20)30376.
    PubMed    
    
    
    
82. MEJIAS M, Gallego J, Naranjo-Suarez S, Ramirez M, et al
    CPEB4 Increases Expression of PFKFB3 to Induce Glycolysis and Activate Mouse and Human Hepatic Stellate Cells, Promoting Liver Fibrosis.
    Gastroenterology. 2020 Mar 10. pii: S0016-5085(20)30328.
    PubMed     Abstract available
    
    
    January 2020
83. LIU X, Xu J, Rosenthal S, Zhang LJ, et al
    Identification of Lineage-specific Transcription Factors That Prevent Activation of Hepatic Stellate Cells and Promote Fibrosis Resolution.
    Gastroenterology. 2020 Jan 20. pii: S0016-5085(20)30117.
    PubMed     Abstract available
    
    
    
84. LIN YH, Zhang S, Zhu M, Lu T, et al
    Mice With Increased Numbers of Polyploid Hepatocytes Maintain Regenerative Capacity but Develop Fewer Tumors Following Chronic Liver Injury.
    Gastroenterology. 2020 Jan 20. pii: S0016-5085(20)30116.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Liver Cirrhosis is free of charge.